Tags Biotech M&A Big Pharma Races to Snap Up Biotech Assets as $170 Billion Patent Cliff Nears businessx January 7, 2026 Global pharmaceutical giants are accelerating efforts to acquire biotech companies and late-stage drug assets as the industry braces for a
